Conatus Pharmaceuticals Inc. to Report Third Quarter 2013 Financial Results on November 14, 2013
11/8/2013 9:12:27 AM
SAN DIEGO, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will report financial results for the third quarter ended September 30, 2013 on Thursday, November 14, 2013. Conatus's management team will host a conference call and audio webcast at 4:30 p.m. Eastern Time on Thursday, November 14, 2013 to discuss the quarterly results and provide a corporate update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by